How CRISPR can create more ethical eggs

Credit: Labiotech
Credit: Labiotech
Over the past couple of decades, Western consumers have shown an increasing appetite for more ethical eggs. The European Union and a number of American states have banned the use of battery cages for egg-laying hens and the cage-free egg market segment has been growing for years. In some countries, free-range eggs outsell caged eggs and a number of powerful corporations like Walmart and McDonalds have pledged to source and sell only cage-free eggs within the next few years.

The growing popularity of so-called “cruelty-free” eggs is an indicator that and more more consumers want to feel good about what they eat. But there is another ethical dilemma within the global poultry production system that produces the 1.2 trillion and counting eggs consumed each year.

‘Massive financial and ethical challenge’

There are two types of chickens: the broilers that we eat and the layers that produce the eggs. The layers don’t have enough meat to make them useful for human consumption and since only hens can lay eggs, that leaves the male layers useless. As a result, billions of newly hatched male layer chicks are killed each year. If you have the stomach for it, plenty of videos show this not-so-secret practice in gory detail.

Now the Israeli ag-tech startup eggXYt has found a way to humanely address this dilemma through the use of CRISPR — the gene editing technique that allows scientists to make targeted, specific genetic tweaks.

“Every year, 4 billion male chicks are incubated, hatched and manually sexed, only to be disposed of, creating a massive financial and ethical challenge,” eggXYt co-founder and CEO Yehuda Elram told the Alliance for Science.

Dani Offen and Yehuda Elram, founders of eggXYt. Credit: eggXYt

The process of transporting 8 billion eggs to hatcheries, where they are incubated for three weeks before being manually sex-sorted by workers who then dispose of all of the males, results in a global financial loss of $1 billion, according to eggXYt. And then there’s all the carnage.

Inserting biomarkers

But by using CRISPR, eggXYt’s scientists can edit the genes of chickens to make them lay sex-detectable eggs.

“The chicken is made sex-detectable by inserting a biomarker onto the male sex chromosome,” Elram explained. “The biomarker is able to be picked up by our scanner, which then mechanically sorts the eggs based on the presence of the biomarker. Because the biomarker is only on the male chromosome, only the male chicks receive it.”

Credit: eggXYt

Female eggs are unaffected by the edit. So, when those eggs hatch and eventually become layers, they are biologically identical to non-edited hens. The biomarkers in the male eggs, however, can be identified via an electro-optical scanner. The unaltered female eggs give off no signal, but the biomarkers in the male eggs shine a bright yellow.

The eggXYt system works as a “gatekeeper” that keeps the male eggs from ever entering hatcheries in the first place. Instead, they can be sold for consumption or to the pharmaceutical and cosmetics industries. The global egg industry saves the costs and the ethical conundrum of killing half of its product and billions of additional eggs are added to the global market to help meet growing demand.

“EggXYt allows hatcheries to identify the sex of a chick embryo before incubation, in a non-invasive way,” Elram said. “This means that hatcheries are able to save costs on incubating and manually sexing the male chicks, and they are able to create an additional revenue stream from the sale of the non-incubated male eggs.”

The poultry industry can also save on feed costs and improve its food conversion rates. In a video on the company’s website, Elram says the sex-detection technology has the potential to “fundamentally change the economics of the poultry and egg industries.” According to the company, a number of investors have seen the economical potential.

“Our company attracts a lot of investor interest because of our strong impact narrative, our use of cutting edge science and the fact that we are introducing new efficiency into a traditional industry, which creates more value for all players involved and strong financial incentives for them to adopt our solution,” Elram said.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

If eggXYt’s gambit succeeds, consumers may one day in the not-too-distant future see egg cartons labelled “culling-free” next to the “free-range” options already on the market. Elram said that both consumers and governments are becoming increasingly aware of the negativity of male chick culling, pointing to pending legislation to ban the practice in GermanyFrance, Spain and Switzerland. In the US, the United Egg Producers has also called ending chick culling “a priority and […] the right thing to do”.

EggXYt hopes that, in following with the US Department of Agriculture’s decision to not regulate gene-edited plants, its gene-edited eggs will similarly avoid burdensome regulations.

Justin Cremer is a professional communicator who has spent nearly two decades alternating between journalism and marketing/communications. Find Justin on Twitter @MrJustinCremer

A version of this article was originally posted at the Cornell Alliance for Science and has been reposted here with permission. The Cornell Alliance for Science can be found on Twitter @ScienceAlly

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-14-at-11.11.06-AM
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
ChatGPT Image May 28, 2026, 08_16_38 PM
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
fda_logo_decimated
Viewpoint: RFK, Jr.’s FDA is on a screaming downward path—and why it may never recover
edb7f6d7-2370-418f-9578-74e29678e35c
Facts & Fallacies Podcast: Nicotine vaping—public health miracle, or risk to children? Professor Cliff Douglas
ChatGPT-Image-May-22-2026-10_56_42-AM-2
‘It’s not super useful’: As wariness about AI grows, Trump proposes rollback of healthcare safeguards
ChatGPT-Image-May-22-2026-10_26_09-AM
Gutting the National Science Board: How the Trump-RFK, Jr. crusade is erasing the separation of science and state
ChatGPT-Image-May-28-2026-11_31_47-AM-2
Relying on your doctor or AI miracle cure, death and debilitation? Neurologist makes the wrong choice
Screenshot-2026-05-27-at-10.51.25-AM
Viewpoint: ‘Monsanto’ blues—Planned Netflix movie promises yet another round of anti-glyphosate disinformation
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-May-26-2026-11_51_01-AM
Viewpoint: RFK, Jr.’s ‘sadistic’ solution to autism, depression, and other ills looks a lot like prison camp
Picture1
The Orange Bowl without oranges: Can CRISPR save Florida citrus?
Screenshot-2026-05-26-at-12.36.18-PM
MAGA’s latest ‘health obsession’? Nicotine patches promoted by ‘Zynfluencers’—including some in the Trump administration 
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.